(FHLC) Fidelity MSCI Health Care - Overview
Etf: Health Care, Pharmaceuticals, Biotechnology, Medical Devices
| Risk 5d forecast | |
|---|---|
| Volatility | 17.8% |
| Relative Tail Risk | -0.77% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.03 |
| Alpha | -7.89 |
| Character TTM | |
|---|---|
| Beta | 0.481 |
| Beta Downside | 0.473 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.87% |
| CAGR/Max DD | 0.37 |
Description: FHLC Fidelity MSCI Health Care March 05, 2026
FHLC is an exchange-traded fund (ETF) that invests primarily in U.S. healthcare equities. It aims to track the MSCI USA IMI Health Care 25/50 Index, which represents the performance of the healthcare sector. The healthcare sector is characterized by a diverse range of companies, including pharmaceutical firms, biotechnology companies, and healthcare providers. This sector is often considered defensive due to consistent demand for its products and services.
The fund is non-diversified, meaning it concentrates its investments in the healthcare sector rather than spreading them across various industries. Understanding sector-specific risks and opportunities is crucial for non-diversified funds. For further detailed analysis, ValueRay offers comprehensive tools.
Headlines to watch out for
- Healthcare spending growth drives sector revenue
- Pharmaceutical innovation impacts drugmaker profitability
- Government policy changes influence healthcare provider income
- Medical device demand fluctuates with economic conditions
- Biotech research breakthroughs create new market opportunities
What is the price of FHLC shares?
Over the past week, the price has changed by -3.01%, over one month by -7.44%, over three months by -7.46% and over the past year by +2.11%.
Is FHLC a buy, sell or hold?
What are the forecasts/targets for the FHLC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |